TRUST Study: Raptiva ® in Hand & Foot Psoriasis

Summary

To evaluate the safety and efficacy of Raptiva ® compared with placebo to control chronic moderate to severe plaque psoriasis involving the hands and/or feet scoring Physician's Global Assessment (PGA - H\&F) greater-than or equal to 3 in subjects not suitable for other systemic therapies including cyclosporine, methotrexate, and Psoralen-Ultraviolet Light A (PUVA).

Timeline

Start

2008-04

Primary completion

2009-06

Completion

2009-06

Drugs

Indications